CHI3L1 and Alzheimer disease: Overall, we observed two distinct mediation patterns: (1) SNPs that affect AD either via alteration in both the Aβ pathology and tau pathology/degeneration components (APOE) or (2) SNPs that affect AD via the injury/inflammation PC only (TMEM106B and CHI3L1).